Figure 6 shows the popularity of each drug as a first-, second- or third-line treatment following breakthrough relapses
Figure 6 shows the popularity of each drug as a first-, second- or third-line treatment following breakthrough relapses. Open in a separate window Fig. first collection MT (54.5%; 6/11). Treatment…